title: Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
authors.affiliation: Department of Geriatric Medicine, Karolinska Institute, Huddinge Hospital, Sweden.
authors.forename: B
authors.initials: B
authors.lastname: Winblad
authors.forename: S
authors.initials: S
authors.lastname: Hill
authors.forename: B
authors.initials: B
authors.lastname: Beermann
authors.forename: S G
authors.initials: SG
authors.lastname: Post
authors.forename: A
authors.initials: A
authors.lastname: Wimo
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000191:economics; D002986:Clinical Trials as Topic / Q000191:economics; D003362:Cost-Benefit Analysis; D003431:Cross-Cultural Comparison; D003704:Dementia / Q000188:drug therapy* / Q000191:economics; D016527:Drug Costs; D005060:Europe; D005544:Forecasting; D017048:Health Care Costs / Q000639:trends; D006801:Humans; D007391:International Cooperation; D018697:Nootropic Agents / Q000191:economics* / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome; D014481:United States
chemical_list: D018697:Nootropic Agents